Rapport Therapeutics, Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-126410 | Mar 26, 2026 | Mar 25, 2026 |
| 144 | — | 0001950047-26-002990 | Mar 25, 2026 | — |
| S-3ASR | S-3ASR | 0001193125-26-099421 | Mar 10, 2026 | — |
| S-8 | S-8 | 0001193125-26-099377 | Mar 10, 2026 | — |
| 10-K | 10-K | 0001193125-26-099360 | Mar 10, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-099336 | Mar 10, 2026 | — |
| 4 | 4 | 0001193125-26-098488 | Mar 9, 2026 | Mar 5, 2026 |
| 144 | — | 0001193125-26-094361 | Mar 5, 2026 | — |
| 4 | 4 | 0001193125-26-059886 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-059883 | Feb 19, 2026 | Feb 17, 2026 |
| SCHEDULE 13G/A | — | 0001172661-26-001034 | Feb 17, 2026 | — |
| 4 | 4 | 0001193125-26-037618 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037603 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037587 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037581 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037570 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-037529 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | 4 | 0001193125-26-019820 | Jan 22, 2026 | Jan 20, 2026 |
| 4 | 4 | 0001193125-26-015350 | Jan 16, 2026 | Jan 15, 2026 |
| 144 | — | 0001950047-26-000482 | Jan 15, 2026 | — |
| 8-K | 8-K | 0001193125-26-005499 | Jan 7, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-005482 | Jan 7, 2026 | — |
| 8-K | 8-K | 0001193125-26-005446 | Jan 7, 2026 | — |
| 4 | 4 | 0001193125-26-002470 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-002469 | Jan 5, 2026 | Dec 31, 2025 |
| 144 | — | 0001193125-26-001213 | Jan 2, 2026 | — |
| 144 | — | 0001193125-26-001211 | Jan 2, 2026 | — |
| 4 | 4 | 0001193125-25-324826 | Dec 18, 2025 | Dec 17, 2025 |
| 144 | — | 0001950047-25-010475 | Dec 17, 2025 | — |
| 144 | — | 0001950047-25-010465 | Dec 17, 2025 | — |
| 4 | 4 | 0001193125-25-321142 | Dec 16, 2025 | Dec 15, 2025 |
| 4 | 4 | 0001193125-25-303910 | Dec 1, 2025 | Nov 26, 2025 |
| 4 | 4 | 0001193125-25-286218 | Nov 18, 2025 | Nov 17, 2025 |
| 4 | 4 | 0001193125-25-286212 | Nov 18, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-004952 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-268096 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-268072 | Nov 6, 2025 | — |
| 4 | 4 | 0001193125-25-241475 | Oct 16, 2025 | Oct 15, 2025 |
| 4 | 4 | 0001193125-25-241472 | Oct 16, 2025 | Oct 15, 2025 |
| 144 | — | 0001950047-25-007977 | Oct 15, 2025 | — |
| 4 | 4 | 0001193125-25-209062 | Sep 19, 2025 | Sep 17, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-091350 | Sep 18, 2025 | — |
| 144 | — | 0001950047-25-007282 | Sep 17, 2025 | — |
| 144 | — | 0001950047-25-007277 | Sep 17, 2025 | — |
| 4 | 4 | 0001193125-25-206203 | Sep 17, 2025 | Sep 15, 2025 |
| 4 | 4 | 0001193125-25-203540 | Sep 15, 2025 | Sep 12, 2025 |
| 4 | 4 | 0001193125-25-203537 | Sep 15, 2025 | Sep 12, 2025 |
| 4 | 4 | 0000950170-25-114325 | Sep 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-200205 | Sep 10, 2025 | Sep 9, 2025 |
| 424B5 | 424B5 | 0001193125-25-200200 | Sep 10, 2025 | — |